The effect of rapamycin and its analogues on age-related musculoskeletal diseases: a systematic review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1720-8319
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The effect of rapamycin and its analogues on age-related musculoskeletal diseases: a systematic review ; day:21 ; month:7 ; year:2022 ; pages:1-17
Aging clinical and experimental research ; (21.7.2022), 1-17
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40520-022-02190-0
- URN
-
urn:nbn:de:101:1-2022093022343179358327
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lin, Hong
- Salech, Felipe
- Lim, Anthony
- Vogrin, Sara
- Duque, Gustavo
- SpringerLink (Online service)
Other Objects (12)
Effect of rapamycin on aging and age-related diseases—past and future
Rapamycin-induced hyperglycemia is associated with exacerbated age-related osteoarthritis
Applications of Lipidomics to Age-Related Musculoskeletal Disorders
Pathophysiology of age-related diseases
Correction to: Rapamycin-induced hyperglycemia is associated with exacerbated age-related osteoarthritis
Immunosenescence and age-related viral diseases
Medical bioremediation of age-related diseases
MicroRNAs in age-related diseases
MicroRNAs in age‐related diseases
Work outcome in persons with musculoskeletal diseases: comparison with other chronic diseases & the role of musculoskeletal diseases in multimorbidity
Immuno (T) herapy for age‐related diseases
Cell‐Based Therapies for Degenerative Musculoskeletal Diseases
Effect of rapamycin on aging and age-related diseases—past and future
Rapamycin-induced hyperglycemia is associated with exacerbated age-related osteoarthritis
Applications of Lipidomics to Age-Related Musculoskeletal Disorders
Pathophysiology of age-related diseases
Correction to: Rapamycin-induced hyperglycemia is associated with exacerbated age-related osteoarthritis
Immunosenescence and age-related viral diseases
Medical bioremediation of age-related diseases
MicroRNAs in age-related diseases
MicroRNAs in age‐related diseases
Work outcome in persons with musculoskeletal diseases: comparison with other chronic diseases & the role of musculoskeletal diseases in multimorbidity
Immuno (T) herapy for age‐related diseases
Cell‐Based Therapies for Degenerative Musculoskeletal Diseases
Effect of rapamycin on aging and age-related diseases—past and future
Rapamycin-induced hyperglycemia is associated with exacerbated age-related osteoarthritis
Applications of Lipidomics to Age-Related Musculoskeletal Disorders
Pathophysiology of age-related diseases
Correction to: Rapamycin-induced hyperglycemia is associated with exacerbated age-related osteoarthritis
Immunosenescence and age-related viral diseases
Medical bioremediation of age-related diseases
MicroRNAs in age-related diseases
MicroRNAs in age‐related diseases
Work outcome in persons with musculoskeletal diseases: comparison with other chronic diseases & the role of musculoskeletal diseases in multimorbidity
Immuno (T) herapy for age‐related diseases